A trial to see whether two anti-malarial drugs — chloroquine, hydroxychloroquine — could prevent the novel coronavirus has begun in the UK’s Brighton and Oxford.
The first UK participants in the global trial are being enrolled on Thursday at the Brighton and Sussex University Hospitals and the John Radcliffe Hospital in Oxford, reports the BBC.
They will be given either hydroxychloroquine or a placebo for three months.
These are the first of a planned 25 UK sites, with results expected by the end of the year.
The trial is open to anyone delivering direct care to coronavirus patients in the UK, as long as they have not been diagnosed with COVID-19.
It will test whether the drugs can prevent healthcare workers exposed to the virus from contracting it.
One of the study’s leaders, Professor Nicholas White at the University of Oxford said: “We really do not know if chloroquine or hydroxychloroquine are beneficial or harmful against COVID-19.”
But, he said, a randomised controlled trial such as this one, where neither the participant nor the researchers know who has been given the drug or a placebo, was the best way to find out.
“A widely available, safe and effective vaccine may be a long way off,” the BBC quoted Professor Martin Llewelyn from Brighton and Sussex Medical School, who is also leading the study.
“If drugs as well-tolerated as chloroquine and hydroxychloroquine could reduce the chances of catching COVID-19, this would be incredibly valuable.”
Another 363 COVID-19 patients have died in Britain as of Tuesday afternoon, bringing the total coronavirus-related death toll in the country to 35,704, Culture Secretary Oliver Dowden said on Wednesday.
The figures include deaths in all settings, including hospitals, care homes and the wider community, Xinhua news agency reported.
As of Wednesday morning, 248,293 people have tested positive for the disease, marking a 2,472 daily increase, the secretary said during the Downing Street briefing.
To help live sport “bounce back”, Dowden announced that he is setting up a taskforce made up of experts on how to find new and different ways to get the industries back up and running.
Also Read – Sadiq Supports Public Inquiry on BAME death toll